Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

118
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
118
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

155
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
155
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

398
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
398
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.9K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

840
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
840
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

12
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
12

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Hepatology (Baltimore, Md.)·2026
Same author

The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study.

Clinical epidemiology·2026
Same author

Amino acids partially override inhibitory effects of octreotide on islet hormone secretion in healthy individuals.

The Journal of physiology·2026
Same author

In sphincter of Oddi patients, amelioration of pain is primarily associated with common bile duct dilation rather than hepatobiliary scintigraphy excretion time or alanine amino transferase - a single centre, retrospective study.

Clinical physiology and functional imaging·2026
Same author

Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy.

bioRxiv : the preprint server for biology·2026
Same author

The effect of ghrelin on insulin sensitivity and beta-cell function after sleeve gastrectomy.

American journal of physiology. Endocrinology and metabolism·2026

Related Experiment Video

Updated: Aug 2, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

980

Postprandial dysfunction in fatty liver disease.

Josephine Grandt1,2, Anne-Sofie H Jensen1,2, Mikkel P Werge1

  • 1Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.

Physiological Reports
|April 20, 2023
PubMed
Summary
This summary is machine-generated.

Postprandial (after-meal) metabolic dysfunction is evident in non-alcoholic fatty liver disease (NAFLD) and cirrhosis. Assessing these after-meal changes is crucial for understanding metabolic health in NAFLD patients.

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.0K
Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
08:20

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

1.9K

Related Experiment Videos

Last Updated: Aug 2, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

980
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.0K
Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
08:20

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

1.9K

Area of Science:

  • Hepatology
  • Metabolic Disorders
  • Liver Disease Research

Background:

  • Fatty liver disease is typically studied under fasting conditions, overlooking its role in postprandial homeostasis.
  • The liver's function in postprandial metabolic regulation necessitates investigating mealtime disturbances in liver conditions.

Purpose of the Study:

  • To investigate postprandial metabolic changes in individuals with non-alcoholic fatty liver disease (NAFLD) and cirrhosis compared to healthy controls.
  • To identify markers of metabolic dysfunction in the postprandial state in these patient groups.

Main Methods:

  • A comparative study involving healthy controls, biopsy-proven NAFLD patients, and cirrhosis patients with hepatic steatosis.
  • Participants underwent either a fasting test or a standardized mixed meal test, with blood and liver biopsies collected over 120 minutes.
  • Plasma levels of glucose, insulin, C-peptide, glucagon, and FGF21 were measured.

Main Results:

  • Postprandial glucose and C-peptide levels were significantly elevated in NAFLD and cirrhosis patients compared to healthy individuals.
  • Hyperglucagonemia and impaired glucose tolerance were observed in NAFLD and cirrhosis patients without type 2 diabetes.
  • Fibroblast Growth Factor 21 (FGF21) levels were elevated in NAFLD and cirrhosis, with higher glucagon concentrations found in liver vein blood versus peripheral blood.

Conclusions:

  • Postprandial metabolic disturbances, including impaired glucose tolerance and hyperinsulinemia, are present in NAFLD and cirrhosis patients even without type 2 diabetes.
  • Assessing postprandial metabolic status is important for a comprehensive understanding of metabolic health in non-alcoholic fatty liver disease.
  • Hyperglucagonemia may indicate glucagon resistance in NAFLD and cirrhosis.